Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure.

Authors
Type
Published Article
Journal
Expert Opinion on Pharmacotherapy
1744-7666
Publisher
Informa UK (Taylor & Francis)
Publication Date
Volume
12
Issue
18
Pages
2771–2779
Identifiers
DOI: 10.1517/14656566.2011.626770
PMID: 21999703
Source
Medline
License
Unknown

Abstract

The FDC of 20 mg enalapril-maleate and 10 mg lercanidipine-hydrochloride seems to be effective and well tolerated in clinical practice. It improved vascular surrogate end points, including pulse pressure, blood pressure variability and microalbuminuria.

Statistics

Seen <100 times